| David Sacks, MD | |
|
420 S 5th Ave, West Reading, PA 19611 | |
| (484) 628-8059 | |
| Not Available |
| Full Name | David Sacks |
|---|---|
| Gender | Male |
| Speciality | Interventional Radiology |
| Experience | 44 Years |
| Location | 420 S 5th Ave, West Reading, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518962042 | NPI | - | NPPES |
| 001215742 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0204X | Radiology - Vascular & Interventional Radiology | MD-026760-E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reading Hospital | West reading, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tower Health Medical Group | 7618889213 | 577 |
News Archive
Specific respiratory microbiome communities may be linked to influenza susceptibility, according to a study published January 9, 2019 in the open-access journal PLOS ONE by Betsy Foxman from the University of Michigan, USA, and colleagues
HIV-AIDS did not come from oral polio vaccine contaminated with chimpanzee virus, reports a research team led by a University of Arizona evolutionary biologist
Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of pancreatic cancer.
The Drug Enforcement Administration has issued a new guideline intended to help ease the delay some nursing home residents face in receiving certain painkillers and anti-anxiety medications.
› Verified 8 days ago
| Entity Name | West Reading Radiology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700848280 PECOS PAC ID: 3274434246 Enrollment ID: O20040114000452 |
News Archive
Specific respiratory microbiome communities may be linked to influenza susceptibility, according to a study published January 9, 2019 in the open-access journal PLOS ONE by Betsy Foxman from the University of Michigan, USA, and colleagues
HIV-AIDS did not come from oral polio vaccine contaminated with chimpanzee virus, reports a research team led by a University of Arizona evolutionary biologist
Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of pancreatic cancer.
The Drug Enforcement Administration has issued a new guideline intended to help ease the delay some nursing home residents face in receiving certain painkillers and anti-anxiety medications.
› Verified 8 days ago
| Entity Name | Tower Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609291350 PECOS PAC ID: 7618889213 Enrollment ID: O20040311000072 |
News Archive
Specific respiratory microbiome communities may be linked to influenza susceptibility, according to a study published January 9, 2019 in the open-access journal PLOS ONE by Betsy Foxman from the University of Michigan, USA, and colleagues
HIV-AIDS did not come from oral polio vaccine contaminated with chimpanzee virus, reports a research team led by a University of Arizona evolutionary biologist
Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of pancreatic cancer.
The Drug Enforcement Administration has issued a new guideline intended to help ease the delay some nursing home residents face in receiving certain painkillers and anti-anxiety medications.
› Verified 8 days ago
| Entity Name | West Grove Clinic Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790856078 PECOS PAC ID: 4789685033 Enrollment ID: O20070129000812 |
News Archive
Specific respiratory microbiome communities may be linked to influenza susceptibility, according to a study published January 9, 2019 in the open-access journal PLOS ONE by Betsy Foxman from the University of Michigan, USA, and colleagues
HIV-AIDS did not come from oral polio vaccine contaminated with chimpanzee virus, reports a research team led by a University of Arizona evolutionary biologist
Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of pancreatic cancer.
The Drug Enforcement Administration has issued a new guideline intended to help ease the delay some nursing home residents face in receiving certain painkillers and anti-anxiety medications.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Sacks, MD Po Box 13579, Reading, PA 19612-3579 Ph: (484) 628-0799 | David Sacks, MD 420 S 5th Ave, West Reading, PA 19611 Ph: (484) 628-8059 |
News Archive
Specific respiratory microbiome communities may be linked to influenza susceptibility, according to a study published January 9, 2019 in the open-access journal PLOS ONE by Betsy Foxman from the University of Michigan, USA, and colleagues
HIV-AIDS did not come from oral polio vaccine contaminated with chimpanzee virus, reports a research team led by a University of Arizona evolutionary biologist
Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of pancreatic cancer.
The Drug Enforcement Administration has issued a new guideline intended to help ease the delay some nursing home residents face in receiving certain painkillers and anti-anxiety medications.
› Verified 8 days ago
Dr. Michael Anthony Romeo, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave, Ste. 135, West Reading, PA 19611 Phone: 610-988-8936 Fax: 610-736-0721 | |
Edward C. Fallon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave, Ste 135, West Reading, PA 19611 Phone: 484-628-8108 Fax: 484-628-8400 | |
Daniel J. O'shea, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave, Ste 135, West Reading, PA 19611 Phone: 484-628-8108 Fax: 484-628-8400 | |
Michael Paul Feightner, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave, Suite 135, West Reading, PA 19611 Phone: 610-988-8157 Fax: 610-736-0721 | |
Elaine R. Lewis, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave, Ste 135, West Reading, PA 19611 Phone: 484-628-8934 Fax: 484-628-8400 | |
Michael Lester Haas, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8067 Fax: 484-628-9500 |